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Abstract
There is increasing evidence that soluble factors in inflammatory central nervous system diseases not only regulate the
inflammatory process but also directly influence electrophysiological membrane properties of neurons and astrocytes. In
this context, the cytokine TNF-a (tumor necrosis factor-a) has complex injury promoting, as well as protective, effects on
neuronal viability. Up-regulated TNF-a expression has also been found in various neurodegenerative diseases such as
cerebral malaria, AIDS dementia, Alzheimer’s disease, multiple sclerosis, and stroke, suggesting a potential pathogenic role
of TNF-a in these diseases as well. We used the neuroblastoma cells SK-N-MC. Transcriptional activity was measured using
luciferase reporter gene assays by using lipofectin. We performed cotransfection experiments of NFAT (nuclear factor of
activated T cells) promoter constructed with a dominant negative version of NFAT (dn-NFAT). Cell death was performed by
MTT (3-(4,5-dimethylthiazol-2-yl)5,5-diphenyltetrazolium bromide) and TUNEL assays. NFAT translocation was confirmed by
Western blot. Involvement of NFAT in cell death was assessed by using VIVIT. P53, Fas-L, caspase-3, and caspase-9
expressions were carried out by Western blot. The mechanisms involved in TNF-a-induced cell death were assessed by using
microarray analysis. TNF-a causes neuronal cell death in the absence of glia. TNF-a treatment results in nuclear translocation
of NFAT through activation of calcineurin in a Ca
2+ independent manner. We demonstrated the involvement of FasL/Fas,
cytochrome c, and caspase-9 but the lack of caspase-3 activation. NB cell death was absolutely reverted in the presence of
VIVIT, and partially diminished by anti-Fas treatment. These data demonstrate that TNF-a promotes FasL expression through
NFAT activation in neuroblastoma cells and this event leads to increased apoptosis through independent caspase-3
activation.
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Introduction
Tumor necrosis factor-a (TNF-a), the most widely studied
cytokine, plays many roles as a signaling and as an effector
molecule in both physiology and pathophysiology of the central
nervous system (CNS) [1]. On the one hand, TNF-a plays a
critical role in brain development, brain physiology, synaptic
plasticity, sleep, circadian rhythm, normal behavior, etc [2]. It has
been shown to induce the activation of glial cells and macrophages
for the production of a variety of neurotoxins and to initiate the
death process in oligodendrocytes and neurons [3]. The
pleiotropic actions of TNF-a are mediated through two distinct
cell surface receptors: 55 kDa TNFR1 (p55, or CD120a) and
75 kDa TNFR2 (also called p75, and CD120b) (reviewed in [4]).
Although it has been described that both TNF-a receptors in the
brain are expressed by neurons and glia [5,6], receptor
distribution varies depending upon activation of either apoptosis
or inflammatory regulation [7,8], and although the functions of
p75 in the brain are still unclear, activation of p55 initiates signals
leading to neuronal apoptosis. These differential patterns of
localization of TNF-a receptors in neuronal and glial cells, their
state of activation and the down-stream effectors, all are thought to
play an important role in determining whether TNF-a will exert a
beneficial or harmful effect on CNS. In addition, TNFRs mediate
the activation of several transcription factors leading to enhanced
gene expression (reviewed in [9]).
In the CNS, resident macrophages, astrocytes and microglia are
able to produce TNF-a, which seems to be proinflammatory
during the acute phase of CNS inflammatory responses, but
immunosuppressive during the chronic phase. One effect through
which TNF-a is neurotoxic is by over-stimulation of the glutamate
receptors, such as the N-methyl-D-aspartate receptor.
The nuclear factor of activated T cells (NFAT) family of
proteins was first discovered by identification of factors involved in
the upregulation of IL-2 in response to TCR stimulation [10].
Since that time, NFAT proteins have been implicated in a wide
variety of cellular processes including cardiac hypertrophy,
learning and memory, and adipocyte differentiation. NFAT
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the cytoplasm of resting cells, and are regulated primarily through
calcium levels in the cell. Upon stimulation, an increase in
intracellular calcium turns on the serine/threonine phosphatase
calcineurin (CaN), which then binds to NFAT and dephosphor-
ylates the protein, causing its nuclear translocation, where they
orchestrate developmental and activation programs in diverse cell
types. Intense CaN expression localized to activated astrocytes
surrounding amyloid plaques in AD model mice [11]. In addition,
Ab(1-42) peptides, the primary constituents of amyloid plaques,
have been shown to potently stimulate CaN-dependent signaling
in cell culture models, brain slices, and intact animals [11,12].
Apoptosis is the predominant form of cell death triggered in
vivo and in vitro by drugs in hematologic malignancies [13]. There
are two major routes by which apoptosis can be induced: (1) the
mitochondrial or intrinsic apoptosis pathway; and (2) the death
receptor-mediated or extrinsic apoptosis pathway. Conversely, the
mitochondrial apoptotic pathway, activated by developmental
cues or cytotoxic stimuli is independent of caspase-8 and Fas-
associated death domain protein (FADD), but involves mitochon-
drial release of cytochrome c, which promotes apoptotic protease-
activating factor-1 (Apaf-1)-mediated activation of caspase-9 [14].
Following its activation, caspase-9 activates the downstream
effector caspase cascade [15]. Initiation of the extrinsic apoptosis
pathway involves ligand-induced aggregation of death receptors
and activation of procaspase-8 or procaspase-10 within the death-
inducing signaling complex [16]. The intrinsic and extrinsic
apoptotic pathways converge at the level of caspase-3 activation.
We report that TNF-a causes cell death in human neuroblas-
toma (NB) cells through NFAT activation and upregulation of
FasL protein. In addition, TNF-a-induced cell death involves
release of cytochrome c from the mitochondria that leads to
caspase-9 activation.
Results
TNF-a causes neuronal cell death in the absence of glia
NB cells were exposed to control medium or to medium
containing various concentrations of TNF-a, and cell survival was
measured by MTT assay 24 h later. TNF-a evoked a dose-
dependent decrease in cell survival starting with a concentration of
10 ng/ml (Figure 1A).
We next examined whether cell death induced by TNF-a was
apoptotic. SK-N-MC cells were treated with TNF-a for 24 h and
assayed for apoptosis by using the TUNEL staining method, which
detects apoptosis-associated DNA strand breaks. As shown in
Figure 1B, the number of TUNEL-positive cells increased after
TNF-a treatment.
Intracellular signaling associated with TNF-a-mediated
neurotoxicity
Recently, NFAT activation has been linked in nervous tissue to
immune/inflammatory cascades commonly associated with aging
and neurodegenerative diseases [17]. To investigate possible
changes in the transcriptional activity of NFAT in NB cells
treated with TNF-a, we performed transient transfection assays
with a reporter plasmid encoding for NFAT. TNF-a was able to
induce NFAT transcriptional activity in SK-N-MC cells in a
concentration-dependent manner (Figure 2A). To ensure the
specificity of the effect observed we pretreated NB cultures with
anti-TNF-a before stimulation with TNF-a, and as expected
NFAT activity was completely inhibited (Figure 2B). To confirm
the role of NFAT on cell death induced by TNF-a,w e
cotransfected the NFAT promoter construct together with a
plasmid encoding a version of NFAT (dnNFAT) that lacks the
trans activation domain, and acts as dominant negative.
Overexpression of this dominant negative version of NFAT
completely inhibited the NFAT promoter-driven transcription
induced by TNF-a in NB cells (Figure 2C).
TNF-a induces Calcineurin Aa expression but no Ca2+
influx in NB cells
In an attempt to determine the role of CaN in TNF-a-induced
NFAT activity, we investigated its expression in control and
stimulated cells. Western blot analysis revealed that TNF-a was
able to increase CaNa isoform expression at any time studied
being statiscally significant at time of 48 h (Figure 3A).
Probably no signaling molecule is so broad in its distribution yet
sospecificinitsfunctions asCa
2+.Ligand bindingofmanyreceptors
results in the activation of PLC, release of inositol 1,4,5-trispho-
sphate (IP3), and a transient release of Ca
2+ from intracellular stores
through IP3 receptors. However, this initial release of Ca
2+ is not
sufficient to activate NFAT target genes in a number of cell types,
and for this an influx of Ca
2+ through specialized activated Ca
2+
channels is required. Consistent with previously published data
about the presence of different Ca
2+ channels on SK-N-MC cells
[18] was the fact pretreatment of NB cultures with nifedipine
Figure 1. TNF-a causes cell death of NB cells in the absence of
glia. A) SK-N-MC cells were treated with TNF-a (2, 5, 10, 20, and 40 ng/
ml) and examined using the MTT assay after 24 h. Data are mean 6 SD
of three independent experiments performed in triplicate. Significant
difference from controls: *p,0.01. B) Apoptosis determined by TUNEL.
SK-N-MC cells were stained and TUNEL visualized under a fluorescence
microscope with either 100 magnification. Bar: 50 mm.
doi:10.1371/journal.pone.0016100.g001
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2+ channels) did not alter the actions of TNF-a
on NFAT-dependent luciferase activity (Figure S1).
TNF-a increases NFAT nuclear translocation of NFAT
Transcriptional activation by NFAT requires its translocation to
the nucleus where it binds to specific recognition sites in the
promoter region of target genes. To dissect the mechanism
responsible for the TNF-a-mediated induction of NFAT activity,
we first assessed NFAT dephosphorylation and translocation to the
nucleus upon treatment with TNF-a. Western blot analysis of
subcellular fractions from SK-N-MC cells showed significant
differences in the dephosphorylation and translocation to the
nucleus of NFAT in stimulated cells 30 min after treatment
(Figure 4A). Rapid translocation of NFAT in response to TNF-a is
consistent with a direct route of activation and suggests that NFAT
pathway is an important regulator of TNF-a-mediated cascades in
SK-N-MC cells.
Stimulation of NFAT does not only involve its nuclear
translocation, but also the intrinsic function of the transactivation
domain, which is located at the N terminus of NFAT [19]. In this
regard, we discarded the regulation of the transactivating function
of NFAT by TNF-a, with transfection experiments with a Gal4-
luc reporter plasmid along with a construct (Gal4-NFAT)
encoding the N-terminal region of NFAT, where the DNA-
binding domain of Gal4 has been joined to the transactivation
domain of NFAT (Figure S2). These results suggest that regulation
of NFAT by TNF-a in human NB cells depends primarily on the
NFAT promoter region.
Upon activation, nuclear NFAT is able to increase transcription
of genes through still not well-understood mechanisms mediated
Figure 2. Activation of NFAT activity in human NB cells by TNF-a. A) NB cells were transfected with a NFAT reporter plasmid, and then
stimulated by TNF-a at different doses. Luciferase activity was measured 16 h later. Results represent the mean 6 SD of three independent
experiments performed in triplicate. Significant difference from control: *p,0.01. B) NB cells were transfected with the NFAT reporter plasmid, and
treated with TNF-a (20 ng/ml) in the presence of anti-TNF-a (10 mg/ml). Activity of NFAT-luc was measured after 16 h. Data are mean 6 SD of three
independent experiments performed in triplicate. Significant difference from stimulated cells: *p,0.01. C) SK-N-MC cells were transfected with the
NFAT-luc reporter plasmid promoter construct plus an empty vector or an expression vector for a dominant negative (dn) of NFAT. Cells were treated
with TNF-a (20 ng/ml) for 16 h and assayed for luciferase activity. Data are from three independent experiments, presented as mean 6 SD. Significant
difference between stimulated cells: **p=0.05.
doi:10.1371/journal.pone.0016100.g002
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NFAT translocation and DNA binding were also able to induce
transactivation mediated by the N-terminal transactivation domain
(TAD) of NFAT proteins [20,21]. Thus, we tested whether TNF-a
had an effect on this step in the NFAT signaling pathway. For this,
SK-N-MC cells were co-transfected with a construct fusing the
transactivation domain of the NFATc2 (1–415) to the Gal4 DNA
binding domain (DBD) along with a Gal4-luc reporter. When the
ability of TNF-a stimulation to increase the transactivation of Gal4-
NFAT TAD was measured, we did not find any change in
transactivation activity on stimulated cells (Figure S2).
Since our results suggest that cell death in SK-N-MC cells
requires NFAT transcription factor which is regulated by the
phosphatase CaN, we therefore analyzed the levels of neurotox-
icity in TNF-a stimulated SK-N-MC cells in the presence of the
CN inhibitor cyclosporin A (CsA) (100 ng/ml) or VIVIT (2 mM), a
peptide that prevents CN from docking to and dephosphorylating
NFAT transcription factors. Pretreatment with either CsA or
VIVIT for 1 h before TNF-a stimulation led to a decrease of
neuronal toxicity, consistent with the notion that this process
requires NFAT (Figure 4B). These data were confirmed by
TUNEL (Figure 4C). In contrast, VIVIT had no effect on viability
of TNF-a-stimulated lymphocytes, a process that has been shown
to be NF-kB dependent (Figure 4D).
Although it has been previously described p53-mediated
dependent and independent pathways in TNF-a-induced apop-
tosis of human brain cells [22], here we did not detect any
variation in p53-Ser46 expression after TNF-a treatment in
human NB cells (Figure S3).
Functional significance of FasL expression by NB cells
CaN-dependent activation of NFAT has been shown to result in
upregulation of the death receptor ligand FasL [23]. FasL binds to
its receptor Fas and triggers the Fas/FasL apoptotic death cascade
that results in cleavage of DNA. To investigate whether TNF-a-
induced activation of NFAT and subsequent apoptosis of SK-N-
MC cells is linked to the Fas/FasL death pathway, we examined the
expression of FasL after TNF-a stimulation. TNF-a upregulated
FasL expression after 16 h of stimulation, and more importantly,
VIVIT inhibited TNF-a-induced FasL protein by 50% (Figure 5A),
suggesting that NFAT activation is required for TNF-a-mediated
FasL expression in NB cells. More important, pretreatment with
Abs specific for Fas significantly blocked the potentiation of cell
death by TNF-a stimulation measured by MTT (Figure 5B), and
LDH release (Figure 5C). Likewise, the antagonist Kp7-6, which
binds FasL and inhibit Fas/FasL interaction, diminished toxicity
induced by TNF-a in NB cells (Figure 5D).
Ingenuity Pathways Analysis of the newly identified
TNF-a regulated genes
Having demonstrated that TNF-a induces caspase-3-independent
cell death in NB cells, we assessed more globally the mechanisms
involved in this TNF-a-induced cell death using microarray analysis.
Therefore, RNA was prepared from unexposed SK-N-MC cells and
exposed to TNF-a for 16 and 24 h. Three biological replicates were
performed per group. To evaluate further the functional pathways in
which the newly identified TNF-a-regulated genes are involved in SK-
N-MC cells we used the Ingenuity Pathway Analysis (IPA) system.
BIRC7 and TNFRSF1B were upregulated after 16 h. At this time,
BIRC3, RELB, and NFKB1 were the only downregulated genes
detected in this analysis (Table 1). More interesting was the analysis
performed after 24 h where differential gene expression analysis
revealed 22 modulated transcripts (6 decreased and 16 increased) in
TNF-a-stimulated cells compared with controls. A partial list of the
most relevant genes is shown in Table 2. Data were normalized using
the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene as
internal control. The cDNA array approach was used to identify genes
of which transcripts might be regulated in NB cells after stimulation
with TNF-a. We used the pathway drawing function of Ingenuity
Pathways Analysis to display gene expression changes related to
apoptosis, as is shown in Figure 6. Intriguingly, the majority of the
upregulated genes were associated with the intrinsic mechanism of cell
death (HIP1, PYCARD, caspase-9). Conversely, several components
of the extrinsic pathway were uniquely upregulated (member 1B of the
TNFR family (TNFRSF1B), member 25 of the TNFR family
(TNFRSF25), and member 1A of the TNFR family (TNFRSF1A)).
TNF-a causes the release of cytochrome c from the
mitochondria, and induces cleavage of 35-kDa active
caspase-9 in NB cells
To determine which caspases are activated in TNF-a-induced
cell death, we stimulated NB cultures for different times, and cell
lysates were prepared to assess caspases activities.
Caspase-3 appears to be an essential component of the
apoptotic machinery in many cell types and a key player in many
types of neuronal apoptosis [24]. We analyzed the ability of TNF-
a to trigger the activation of caspase-3 activity in TNF-a-
stimulated cells versus control ones. In contrast with expected
results, we did not observe significant activation of caspase-3 in
SK-N-MC cells after TNF-a treatment (Figure 7A, B).
Damage to the mitochondria in other paradigms has been
demonstrated to result in the release of mitochondrial cytochrome
c into the cytoplasm and subsequent activation of caspase-9, which
Figure 3. TNF-a induces Calcineurin Aa expression. Top,
representative immunoblots probed with antibodies against CaNa in
NB cultures at different time set points after TNF-a treatment (20 ng/
ml). The membrane was reprobed with a-tubulin antibody to confirm
equal protein loading. Bottom, quantitation of CaNa levels was
performed by densitometry. Values represent means 6 SD of data
from two independent experiments. Significant difference from control:
*p,0.01.
doi:10.1371/journal.pone.0016100.g003
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PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e16100Figure 4. Role of NFAT on TNF-a-mediated cell death. A) Nuclear translocation of NFAT in TNF-a-stimulated SK-N-MC cells. Top, Western blot
analysis of fractionated extracts from SK-N-MC cells incubated with TNF-a (20 ng/ml) for the indicated times. NFAT was detected with the anti-NFAT
672 antiserum. Gels shown are representative of 3 independent experiments. Antibodies directed against a-tubulin/Lamin B1 were used as a protein
loading control. Each data point is the mean of three replications. Densitometric analysis was used to determine the level of cytoplasmic and nuclear
lysates. B) Neuronal death induced by TNF-a is reverted by NFAT inhibition. SK-N-MC cells were untreated (control) or treated with TNF-a (20 ng/ml)
alone or in combination with CsA (100 ng/ml) or VIVIT (2 mM) for 24 h before measuring cellular death by MTT. The results represent the means 6 SD
of three independent experiments performed in triplicate. Significant difference from TNF-a-stimulated cells: *p,0.01. DMSO 10% was used as a
positive control of cell death. C) Apoptosis determined by TUNEL. SK-N-MC cells were stained with TUNEL and visualized under a fluorescence
microscope with either 100 magnification. Bar: 50 mm. D) Human PBLs were incubated with TNF-a in the presence of VIVIT or PDTC. MTT activity was
measured 24 h after. The results represent the means 6 SD of three independent experiments performed in triplicate. DMSO 10% was used as a
positive control of cell death.
doi:10.1371/journal.pone.0016100.g004
NFAT Is Crucial for TNF-a-Induced Neurotoxicity
PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e16100in turn can elicit the activation of caspase-3 [25]. To evaluate
whether mitochondrial release of cytochrome c is involved in
TNF-a-induced cell death, we prepared cytosolic and mitochon-
drial extracts from NB cells at various time points after treatment,
and cytochrome c protein levels were measured by immunoblot
analysis. Cytosolfrom untreated cells did not contain any detectable
cytochrome c protein (data not shown). In contrast, cytosolic
cytochrome c accumulated significantly in TNF-a-stimulated NB
Figure 5. FasL induction by TNF-a in SK-N-MC cells. A) The level of FasL is increased in TNF-a treated NB cells. Protein lysates were prepared
from NB cells 16 h after TNF-a stimulation. Top, lysates were analyzed by Western blot analysis by using antibody directed against FasL. Antibody
directed against a-tubulin was used as a protein loading control. Bottom, densitometric analysis was used to determine the level of FasL expression in
NB cells, with values normalized to tubulin levels. Error bars represent standard errors of the means. Significant difference from untreated cells:
*p,0.01. B) SK-N-MC cells were pretreated with antiFas at the indicated doses before stimulation with TNF-a (20 ng/ml). Cell viability was determined
using the MTT and LDH assays (C). The results represent the means 6 SD of three independent experiments performed in triplicate. Significant
difference from stimulated cells: **p=0.01. D) Inhibition of TNF-a-induced apoptosis in SK-N-MC cells by the antagonistic peptide Kp7-6. SK-N-MC
cells were stimulated with TNF-a in the presence or absence of Kp7-6 at the indicated doses. MTT activity was measured 24 h later. **p=0.02.
doi:10.1371/journal.pone.0016100.g005
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caspase-9 activity was increased by approximately 2-fold at 24 h
after the induction of apoptosis by TNF-a stimulation; this increase
in activity was found to be inhibited greatly in the presence of
VIVIT suggesting that NFAT signaling is, at least in part,
responsible for its activation (Figure 7D).
Discussion
Inflammation is a cardinal host response to injury, tissue
ischemia, autoimmune responses or infectious agents. Although
most inflammatory mediators have relatively few actions in
healthy CNS tissue being expressed at very low, or undetectable,
levels, they are induced rapidly in response to tissue injury or
infection, and exert diverse actions [1].
TNF-a is released during various inflammatory diseases of the
CNS, being synthesized by microglia, astrocytes, and some
populations of neurons [26,27]. Moreover, since TNF-a receptors
are widely expressed by neurons, astrocytes and microglial cells
both direct and indirect actions of TNF-a on neurons must be
considered. The experiments in this study, although performed in
cell cultures, reflect physiological conditions within the brain
during inflammatory CNS diseases. So, when we investigated its
effect on NB cultures, we observed an increase in cell death in
Figure 6. The pathway was assembled using Ingenuity Pathways Analysis (Ingenuity Systems; www.ingenuity.com), and it shows
genes involved in both the extrinsic and intrinsic mechanisms of apoptosis. Official gene symbols are used. Upregulation is represented by
red, and downregulation is represented by green. Color intensity corresponds to the degree of differential regulation.
doi:10.1371/journal.pone.0016100.g006
Table 1. Differentially expressed genes in SK-N-MC cells 16 h post-treatment with TNF-a.
Gene Symbol Description Log ratio up-regulated
BIRC7 baculoviral IAP repeat-containing 7 3,5
TNFRSF1B tumor necrosis factor receptor superfamily, member 1B 2,4
Log Ratio down-regulated
BIRC3 baculoviral IAP repeat-containing 3 22,7
RELB v-rel reticuloendotheliosis viral oncogene homolog B 22,2
NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 22,1
doi:10.1371/journal.pone.0016100.t001
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was able to induce an increase of NFAT transcriptional activity in
NB cells. The specific nature of NFAT activity after TNF-a
treatment was further supported by the fact that pretreatment with
anti-TNF-a as well as dnNFAT overexpression were enough to
completely block the NFAT activation in treated cells. In addition
to NFAT phosphorylation, entry into the nucleus and binding to
DNA, NFAT-dependent transcriptional up-regulation involves
activation of the intrinsic transactivation activity mediated by the
N-terminal TAD of NFAT [20,21]. Here we have observed that
transcriptional activity induced by the Gal4-NFAT fusion protein
was not affected by treatment with TNF-a. The inability of TNF-a
to stimulate the Gal4-NFAT strongly suggests that the transactiva-
tion of NFAT is unlikely to be responsible for the effects observed
in this paper indicating that the regulation of NFAT by TNF-a
depends primarily on the NFAT promoter region.
NFAT proteins are specialized to sense and respond to dynamic
changes in intracellular calcium concentration because of their
ability to rapidly translocate to and from the nucleus via the
opposing activities of CaN and kinases [28]. Calcium/calmodulin
activation of the CaN results in dephosphorylation of target
proteins [29]. Dephosphorylation of NFATc leads to exposure of a
nuclear localization sequence, translocation from the cytoplasm to
the nucleus [30], and transcription of specific target genes. CaN is
inhibited by drugs such as CsA and FK506 through the binding of
these drugs to their appropriate receptors (immunophilins) [31].
Although initially used after organ transplantation because of their
immunosuppressive properties, immunophilin ligands have been a
center of attention as a putative therapeutic strategy for
neuroregeneration and neuroprotection [32,33]. In this regard, it
has been previously described a direct role of calcineurin in
neuroprotection in animal models [34].
Recently Hui et al have described, that direct inhibition of CaN
is neuroprotective in vivo [35], and Sama et al have demonstrated
that specific NFAT inhibition provides nearly complete protection
against IL-1b dependent toxicity [36]. Consistent with this, we
found that TNF-a increased CaN expression in treated NB cells.
Although the aim of the study was not to determine the
mechanism of CaN induction by TNF-a, we can suppose that
given the protracted of induction the response is quite indirect.
Interestingly, the TNF-a-induced apoptosis was shown to be partly
dependent on activation of NFAT as suggested by the significant
attenuation of apoptosis with VIVIT treatment.
It has been previously described that expression of the
membrane-bound death receptor ligand FasL is mediated by
NFAT [37]. When FasL binds to its receptor Fas, the intracellular
machinery associated with the death receptor Fas is activated and
eventually leads to apoptosis by caspase activation and subsequent
DNA cleavage [23]. Moreover, FasL and Fas receptors are widely
expressed in the nervous system in both neurons and glial cells
[38,39]. Here, we show that TNF-a treatment also increased FasL
levels in NB cells, and this increase was suppressed by VIVIT.
Moreover, cell death was completely abrogated in the presence of
different Fas/FasL antagonists. So it is possible that upregulation
of FasL results in TNF-a-induced death of NB cells by inserting
into the cell membrane and binding to its receptor Fas, which is
expressed on the membranes of adjacent neurons, and subse-
quently triggering apoptosis.
Table 2. Differentially expressed genes in SK-N-MC cells 24 h post-treatment with TNF-a.
Gene Symbol Description Log ratio up-regulated
CASP9 Caspase-9, apoptosis-related cysteine peptidase 11,4
PYCARD PYD and CARD domain containing 6,2
CASP1 Caspase-1, apoptosis-related cysteine peptidase 4,7
HIP1 huntingtin interacting protein 1 3,4
DAPK1 death-associated protein kinase 1 3,1
BID BH3 interacting domain death agonist 3,1
BCL3 B-cell CLL/lymphoma 3 3,0
BIRC7 baculoviral IAP repeat-containing 7 2,8
BOK BCL2-related ovarian killer 2,8
CASP6 Caspase-6, apoptosis-related cysteine peptidase 2,5
HTRA2 5-hydroxytryptamine (serotonin) receptor 2A 2,4
BAD BCL2-associated agonist of cell death 2,3
TBK1 TANK-binding kinase 1 2,3
TRADD TNFRSF1A-associated via death domain 2,2
TNFRSF25 tumor necrosis factor receptor superfamily, member 25 2,2
TNFRSF1A tumor necrosis factor receptor superfamily, member 1A 2,0
Log Ratio down-regulated
BCL2L11 BCL2-like 11 (apoptosis facilitator) 24,7
BIK BCL2-interacting killer (apoptosis-inducing) 23,9
CASP3 Caspase-3, apoptosis-related cysteine peptidase 22,7
BCL10 B-cell CLL/lymphoma 10 22,5
BIRC2 baculoviral IAP repeat-containing 2 22,3
CARD9 caspase recruitment domain family, member 9 22,1
doi:10.1371/journal.pone.0016100.t002
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PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16100Figure 7. Effect of TNF-a on cytochrome c release, and cleavage of caspase-9 in SK-N-MC cells. A) NB cells were incubated or not with
TNF-a for the indicated times, and total extracts were immunoblotted with caspase-3 Ab. B) Caspase-3 was measured after 24 h of treatment by flow
cytometry. Treatment with staurosporine 0.5-1 mM for 3 h was used as positive control. C) NB cells were incubated with TNF-a in the presence of CsA
for 24 h. The mitochondria free cytosolic fractions were prepared for Western blot analysis as described under Experimental Procedures. a-tubulin
was used as cytosolic marker and as control for protein loading. The graphs show the mean increase in cytochrome c/caspase-9 (D) activity levels in
TNF-a treated cells compared to that of unstimulated controls. Porine antibody was used as a control to ensure proper fractionation and loading of
mitochondrial pellet. Error bars represent standard errors of the means. Significant difference from stimulated cells: *p,0.01; **p=0.01.
doi:10.1371/journal.pone.0016100.g007
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lymphocyte function and its role in the immune system.
Alternatively, this study provides an example of a role for NFAT
in the context of the nervous system, a role that is becoming more
common. Collectively, our results indicate that NFAT is activated
after TNF-a treatment and that this event leads to increased FasL
expression and apoptosis of NB cells.
TNF-a family ligands are the main inducers of apoptosis in the
CNS and thus contribute to brain injuries in many neurological
diseases. Although many stimuli exist, the final phases of apoptosis
are executed by a few common effector caspases. In nonneuronal
cells, mitochondria have been shown to accelerate activation of
caspases by releasing proapoptotic molecules, cytochrome c, and
the apoptosis-inducing factor. The extrinsic pathway of apoptosis
can be induced through oligomerization of death receptors such as
Fas, TNFR, DR3, TRAIL-R4, and TRAIL-R5 after engagement
with their respective ligands. This oligomerization, in turn, results
in recruitment of adaptor proteins and activation of caspase
cascades. Initial activation of caspase-8 stimulates apoptosis in two
ways: it can directly cleave and activate caspase-3 or, alternatively,
it can cleave Bid, a proapoptotic Bcl2 family member. This
cleaved (or truncated) bid (tBid) is translocated to mitochondria,
inducing cytochome c release, sequentially activating caspases-9
and -3, and resulting in DNA fragmentation and cell death [40].
Caspase-8 is another caspase that, like caspase-9, appears to be
activated upstream of caspase-3 and in addition has been
implicated possibly to play a role in the cell death associated with
neurodegenerative paradigms. Although in array analysis we did
not detect caspase-8 activation, we found an increase of expression
of Bid protein, a Bcl-2 family member, which has been shown to
be a specific substrate of caspase-8 and to play a role in caspase-8-
mediated mitochondrial damage and cell death [41]. It is possible
that caspase-8 activation occurs early in the process of cell death
and that 16 h is relatively late time point for early gene expression.
Furthermore, TNF-a significantly induced the cytosolic release of
cytochrome c which leads to activation of caspase-9, providing
evidence that cell death is mitochondria dependent.
It is important to note that we have found increased several
proapoptotic proteins as HIP-1, which has been shown to activate
caspase-9, DAPK1 which is/calmodulin-dependent serine/threo-
nine kinase, or Pycard which was upregulated 6-fold in TNF-a-
stimulated cells, and has been shown to associate with Bax, a key
protein in the apoptotic cascade that induces cytochrome c release
from the mitochondria [42]. This effect ultimately leads to
activation of caspase-9, which also is upregulated more than
11-fold.
Surprisingly, the treatment with TNF-a had no effect on
caspase-3 activation. Previously Kuida et al demonstrated a
caspase-9 dependent and caspase-3 independent apoptotic path-
way, since thymocytes from caspase-9
-/- mice are resistant to
gamma irradiation and dexamethasone, whereas thymocytes from
caspase-3
-/- mice are sensitive, suggesting that other caspases are
directly activated by caspase-9 [43]. Future studies are necessary to
elucidate the downstream target of caspase-9.
Moreover, we detected upregulation of proteins as BOK, and
BAD. BOK promotes both caspase-dependent and caspase-
independent apoptosis at the level of mitochondria in various cell
types by promoting the release of proapoptotic mitochondrial
factors to the cell cytosol. Once BAD is dephosphorylated
(posttranslational modification), it is active; it translocates to the
outer membrane of the mitochondria, and forms heterodimers
with BCL-XL to block BCL-XL antiapoptotic function.
Due to the huge impact of TNFR modulation on many
disorders, the potential benefits of specific, targeted TNFR
therapeutics even for CNS diseases seem likely. Therefore,
targeting components of downstream signaling scaffolds or specific
TNF receptor conformations associated with a particular down-
stream pathway provides the opportunity to block the pathogenic
component of TNF-a signaling while preserving the beneficial
component. Nevertheless, the neuroprotective effects of NFAT
inhibition observed here suggest that NFAT may be a promising
molecular target for the treatment of several neurodegenerative
diseases. The proposed TNF-a-induced cell death signaling
pathway mediated by NFAT is shown in Figure 8.
Materials and Methods
Cell culture and treatments
The NB cell line, SK-N-MC (from ATCC HTB10), was
routinely grown in RPMI 1640 (Biochrom KG Seromed, Berlin,
Germany) containing 10% heat-inactivated fetal calf serum, 1%
penicillin/streptomycin, and 2 mM L-glutamine at 37uC and 5%
CO2.
RhTNF-a was from Promega (Promega Corporation, WI,
USA). Anti-human TNF-a neutralizing antibody was purchased
from R&D Systems (Europe, Abingdon, UK). CsA was purchased
from Sigma (St. Louis, MO). Pyrrolidine dithiocarbamate (PDTC)
(an NF-kB inhibitor), and nifedipine were from Santa Cruz
Biotechnology (Inc. CA, USA). Antibodies specific for Fas were
from ENZO (Alexis). 11R-VIVIT (NFAT inhibitor cell perme-
able), and the Fas/FasL antagonist, Kp7-6, were from Calbio-
chem, (Merck KGaA, Darmstadt, Germany). Purified mouse anti-
cytochrome c monoclonal antibody was from BD Pharmingen (BD
Biosciences Pharmingen, Becton Dickinson France).
Plasmid Constructs
The pNFAT-luc reporter plasmid was a gift from Dr. G. R.
Crabtree (Department of Pathology, Howard Hughes Medical
Institute, Stanford University Medical School, Stanford, CA
94305, USA). It contains three tandem copies of the distal NFAT
site of the human IL-2 promoter fused to the minimal human IL-2
promoter. The dominant negative NFATc1 (pSH102C.....418),
was generously provided by Dr. G.R. Crabtree. The Gal4-
hNFATc2(1–415) construct contains the first 415 amino acids of
the human NFATc2 fused to the DNA binding domain (DBD) of
the yeast Gal4 transcription factor (amino acids 1–147) [19] in the
parental Gal4-DBD plasmid. The Gal4-luc reporter plasmid
includes five copies of Gal4 DNA binding sites fused to the
luciferase gene.
Transcription Assays
Transcriptional activity was measured using luciferase reporter
gene assays in transiently transfected cells by Lipofectin reagent as
recommended by the manufacturer (Life Technologies, Inc.,
Grand 8 Island, NY, USA). In cotransfection experiments, 0.15-
0.5 mg/ml of the correspondent expression plasmid was included.
The total amount of DNA in each transfection was kept constant
by using the corresponding empty expression vectors. Protein
contents were measured using the bicinchoninic acid method
(BCA protein assay kit from Pierce, Rockford, IL, USA) according
to the manufacturer’s instructions. Luciferase activity was
determined by using a luciferase assay kit (Promega, Madison,
WI, USA) with a luminometer 1450 Microbeta Luminiscence
Counter. The efficiency of transfection was measured using the
pSV-b-Galactosidase Control Vector Kit (Promega Corporation
Madison) following manufactures indications. The data presented
are expressed as fold induction respect untreated cells of at least 3
independent experiments.
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10 ng of the Gal4DBD-NFAT construct and 100 ng of 5XGal4
luciferase reporter and cultured with or without TNF-a (20 ng/
ml). Reporter activity is expressed as fold induction above control.
Western blot analyses
Cells were exposed to different stimuli, washed with phosphate-
buffered saline (PBS) and lysed with buffer lysis. Protein contents
were measured using BCA protein assay according to the
manufacturer’s instructions. Samples were separated into a 10-
15% SDS polyacrylamide gel and blotted onto a polyvinylidene
fluoride (PVDF) membrane (Millipore, Bedford, MA, U.S.A.) by
semidry transference blotting. Membranes were blocked overnight
at 4uC using Rotiblock (Roth, Karlsruhe) before incubation with
the primary antibody. Rabbit anti-Calcineurin A polyclonal
antibody (Stressgen, MI, USA), phosphor-p53 (Ser46), FasL
antibody, Caspase-9 (C9) mouse mAb, and Caspase-3 (3G2)
mouse Ab (Cell Signaling Technology, Inc), anti-porine (a gift of
Dr. Mar Gonza ´lez, CIB-CSIC, Madrid, Spain) were used as
primary antibodies as appropriate. To detect NFAT nuclear
translocation, nuclear and cytosolic protein extracts were obtained
using Nuclear/Cytosolic fractionation kit (MBL International).
After SDS-PAGE and blotting as above, cells were incubated with
an anti-NFATc2 serum (gift from Dr. J. M. Redondo, Centro de
Biologı ´a Molecular, Universidad Auto ´noma, Madrid, Spain) (1/
3000) for 2 h at room temperature. Membranes were washed and
incubated with horseradish peroxidase-conjugated secondary
antibody (Amersham-Pharmacia Biotech; 1:10000) for one hour
at room temperature. Proteins were detected using the enhanced
chemiluminescence system (Amersham-Pharmacia Biotech).
In all cases, equal amounts of total protein were analyzed across
groups. We used a-tubulin (Sigma, St. Louis, MO), and Lamin B1
(Santa Cruz Biotechnology Inc), as loading control for total/
cytoplasmatic, and nuclear extracts respectively.
Figure 8. A proposed model for TNF-a-induced cell death in NB cells.
doi:10.1371/journal.pone.0016100.g008
NFAT Is Crucial for TNF-a-Induced Neurotoxicity
PLoS ONE | www.plosone.org 11 January 2011 | Volume 6 | Issue 1 | e16100Cytochrome c Release Assays
Cells were harvested, resuspended in 1 ml of lysis buffer
(10 mM Tris, 250 mM Sacarosa, 1 mM EDTA, and complete
proteinase inhibitors (Roche Applied Science)), and lysed by
freeze/thaw, and centrifuged at 7506 g for 10 min. The
supernatant was centrifugated again at 100006g for 20 min.
Supernantants, containing cytosolic proteins were analyzed by
Western blot.
RNA preparation
RNA from SK-N-MC cells cultured with or without TNF-a (16
or 24 h), was prepared using RNAEasy mini kits (Qiagen).
Measurement of cell death and apoptosis
Neuronal cell viability was assessed by the release of lactate
dehydrogenase (LDH) into the culture medium, which indicates
loss of membrane integrity and cell death. LDH activity was
measured using a commercial kit (Cytotoxicity Detection Kit
(Roche Applied Science)) according to manufacturer’s protocol.
Percent cell death is determined by the amount of LDH measured
in the medium divided by the amount of LDH after addition of
1% Triton-X 100.
MTT assay
Mitochondrial activity (a measure of cellular viability) was
measured with the MTT assay (Sigma, St. Louis, MO) as per
manufacturer’s protocol.
Fragment end labeling of DNA (TUNEL)
Fragmented DNA was detected in situ by the terminal
deoxynucleotidyl transferase (TdT)-mediated binding of 39-OH
ends of DNA fragments generated in response to apoptotic signals,
using a commercially available kit from Roche as per manufac-
turer’s protocol.
Taqman Human Apoptosis Array-Real-Time RT-PCR
RNA (1 mg) from NB cells exposed or not to TNF-a was used to
generate cDNA and then assessed by TaqMan assays (Applied
Biosystems, Darmstadt, Germany). Briefly, random hexamers
were used to prime RNA samples for reverse transcription using
MultiScribe (Applied Biosystems, Darmstadt, Germany) reverse
transcriptase, after which PCR products for all the genes tested in
this report were assessed in triplicate wells using TaqMan
predeveloped assay reagents. The assay contains for 93 human
genes in addition to 3 endogenous controls (18S, ACTB,
GAPDH). Relative transcript levels were determined by the
following formula: 1/(DCt target-DCt control), where Ct is the
threshold cycle during the exponential phase of amplification.
Real-time quantitative RT-PCR was performed on an ABI
7900HT system (Applied Biosystems, Darmstadt, Germany).
Microarray data processing
Real-time PCR data were analyzed using the Sequence detector
version 2.2.2 software supplied with the 7900 HT Fast-Real-Time
PCR System (Applied Biosystems, Darmstadt, Germany). Relative
expression of the transcripts was measured in the TaqMan 7900
HT Fast Real-Time PCR system (Applied Biosystems, Darmstadt,
Germany). Stimulated samples were normalized to the corre-
sponding medium-only control. Normalized data were then
imported and analyzed using Ingenuity Pathway Analysis software
(Ingenuity Systems, Mountain View, CA, USA). Pathway analysis
revealed biologic pathways altered in SK-N-MC cells following
exposure to TNF-a. Next, the raw expression values for
experimental (TNF-a exposed) and control (medium only) were
compared to identify those genes with the greatest difference.
Those genes detected were analyzed further by Western blot.
IPA: Network, gene ontology, and canonical pathway
analysis
Unsupervised cluster analysis gene accession numbers were
imported into the version 3.1 IPA software (Ingenuity Systems,
Mountain View, CA, USA) and the gene products were
categorized based on location, cellular components, and reported
or suggested biochemical, biologic, and molecular functions using
the software. The Ingenuity Pathways Knowledge Base is
currently the world’s largest database of knowledge on biological
networks. We exploited this database to define the presence of
functional associations within the genes detected by microarray
analysis and to identify differences between the ontological gene
classes that were enriched among differ expressed genes. This
ontological gene classification provides the controlled vocabulary
to describe gene and gene product attributes.
Statistical analysis
The data were expressed as the mean 6 SD from three to six
independent experiments. Statistical significance between groups
was determined by two-tailed Student’s t test. Differences were
considered significant when p,0.05.
Supporting Information
Figure S1 L-VSCCs are not involved in CaN/NFAT
activation in NB cells in response to TNF-a. NB cells were
transfected with NFAT reporter plasmid and pretreated with
nifedipine (10 mM) at the indicated times before TNF-a
stimulation. Luciferase activity was measured 16 h later. Results
are the mean 6 SD of four different experiments and fold
induction was normalized to TNF-a treated cells.
(TIF)
Figure S2 TNF-a does not induce any increase of NFAT
transactivation. Cells were cotransfected with 10 ng of the
Gal4DBD-NFAT construct and 100 ng of 5XGal4 luciferase
reporter and cultured with medium in basal condition or cultured
with TNF-a (20 ng/ml). Reporter activity is expressed as fold
induction above control. Values represent means 6 SD of
triplicate cultures.
(TIF)
Figure S3 P53 is not involved in TNF-a-mediated cell
death. p53-PSer46 protein levels were determined by Western
blot analysis. Cell lysates from untreated or stimulated cells for the
indicated times were separated by SDS-PAGE on 10% acrylamide
gel, blotted, and incubated with antibodies against p53-PSer46.
(TIF)
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